women's health
| 6 min read
Sabrina Johnson at Daré Bioscience is redefining contraception with Ovaprene, a non-hormonal, monthly option for safe and effective birth control.
| 8 min read
Lundbeck Therapeutics is testing a monoclonal antibody that targets a novel neuropeptide in a Phase 2b clinical trial.
| 8 min read
Bacteria from healthy vaginas show promise in protecting women from pathogens, but advancing their development requires more funding and research.
| 5 min read
Industry leaders predict the most exciting advances in drug discovery and development in the coming year.
| 3 min read
Doctors have been treating bacterial vaginosis with the same antibiotic for decades. This fatty acid could change that.
Available on Demand
How do forever chemicals impact cardiovascular health in postmenopausal women?
| 4 min read
Profiling over 100,000 genomes, researchers identified rare mutations associated with early menopause and cancer, and that some mutations pass down to children.
| 3 min read
Organ-on-a-chip technology can replicate the cervix microenvironment in bacterial vaginosis.
| 3 min read
Placental macrophages play a role in the immune response against pathogens.
| 4 min read
Researchers discovered that a cytokine surge during mid-gestation in mice influenced anxiety behavior in offspring.
Page 1 of 3 - 24 Total Items
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
SubscribeSponsored
Harnessing liver-on-a-chip models for drug safety
Discover how researchers leverage microphysiological systems in toxicology studies.
Enhancing bioanalytical studies with centralized data management
Learn how researchers can improve compliance and efficiency with advanced LIMS solutions.
Explained: How are metabolite biomarkers improving drug discovery and development?
By offering a rich source of insights into disease and drugs, metabolite biomarkers are at the forefront of therapeutic exploration.
